Skip to main content
snıff

Golden Retriever

Lifespan
13.2 years
95% CI 13.1 to 13.2 · McMillan 2024, n=11,506
Most carried variant
Ichthyosis
28% of 12,881 tested · Donner 2023
Behind this page
3,523 dogs
in the atlas · 12,881 tested for variants
Also carried:Progressive Retinal Atrophy · 2.8%Progressive Rod-Cone Degeneration · 2.7%

Golden Retrievers have a cited life expectancy of 13.2 years (McMillan 2024 / VetCompass, n=11,506, 95% CI 13.1 to 13.2). The most carried tested variant is Ichthyosis, in 28% of 12,881 Golden Retrievers tested (Donner 2023), then Progressive Retinal Atrophy (2.8%) and Progressive Rod-Cone Degeneration (2.7%).

Golden Retriever
Photo: Janneke Vreugdenhil Anka Friedrich · Public domain · Wikimedia
See in the atlas → From CanVAS GRLS cohort The Heroes →
The question every Golden owner asks

Golden Retrievers and cancer

Yes, Goldens face cancer more than almost any breed. No, it is not the whole story, and you are not powerless. We wrote it all down plainly: the real number, what no DNA test can tell you, the few things that genuinely help, and the 196 of the most-studied Goldens on Earth who simply grew old.

Read the full picture →
GRLS · published cohort numbers

What the lifetime study has measured so far

The Golden Retriever Lifetime Study (Morris Animal Foundation) enrolled 3,044 goldens (puppyhood follow-up, still running). These are cohort rates from published papers, interim where the study is ongoing, not a prediction for your dog. Separately, Sniff’s atlas marks 3,197 GRLS Heroes among mapped dogs (that is an atlas count, not the study’s enrollment figure).

  • Hemangiosarcoma 7.65%
    of 3,044 enrolled · crude so far · Hillman et al. 2023 (GRLS haemangiosarcoma)
  • Lymphoma / leukemia 85
    cases interim · as of 2021-05-31 · Labadie et al. 2022 (GRLS cohort profile)
    Molecular drivers →
  • Mast cell tumor 10
    cases interim · as of 2021-05-31 · Labadie et al. 2022 (GRLS cohort profile)
  • Osteosarcoma 8
    cases interim · as of 2021-05-31 · Labadie et al. 2022 (GRLS cohort profile)
    Molecular drivers →

Full notes and aging/mortality rows on the GRLS cohort page. Cancer endpoint counts are running totals while the study continues.

Mendelian-disease genetics

What genetic diseases do Golden Retrievers carry?

From a panel of 250 Mendelian-disease variants screened in 1,054,293 dogs (Donner et al. 2023), Golden Retrievers carry 33 of them at observable frequency. Carrier frequency is not clinical risk. Most recessive variants require two copies for disease expression; many dominant variants show incomplete penetrance. Read this as a population fingerprint of what's in the gene pool, not a per-dog prediction.

Ichthyosis (Discovered in the Golden Retriever)
Autosomal recessive
high 27.5%
n = 12,881 dogs · 1 variant tested · OMIA:001588-9615 · omia.org →
PNPLA1what this gene does

PNPLA1 is a gene involved in maintaining the skin's barrier by helping produce essential fats that keep the skin healthy and hydrated.

For your dog: If your dog is from a breed known to carry PNPLA1 variants and shows persistent dry, flaky skin, it's worth discussing with your vet to understand if genetics might be playing a role.

Cystinuria Type I-B (SLC7A9 p.A217T)
Autosomal recessive (Incomplete penetrance)
marker disputed 23.7%
n = 12,881 dogs · 2 variants tested · OMIA:001880-9615 · omia.org →
SLC7A9what this gene does

SLC7A9 is a gene that helps transport certain amino acids in the kidneys. It plays a role in how the body handles cystine, an amino acid that can form crystals.

For your dog: If your dog is a carrier, it’s worth discussing with your vet to monitor urinary health and catch any issues early.

Progressive Retinal Atrophy (Discovered in the Golden Retriever; GR_PRA2)
Autosomal recessive
low 2.8%
n = 12,881 dogs · 1 variant tested · OMIA:001984-9615 · omia.org →
Progressive Rod-Cone Degeneration (prcd-PRA)
Autosomal recessive
low 2.7%
n = 12,860 dogs · 1 variant tested · OMIA:001298-9615 · omia.org →
PRCDwhat this gene does

PRCD is a gene involved in the health of a dog's retina, the part of the eye that detects light and helps with vision.

For your dog: If your dog belongs to a breed known to carry PRCD changes, it's worth discussing eye health and potential genetic testing with your vet.

Progressive Retinal Atrophy (Discovered in the Golden Retriever; GR_PRA1)
Autosomal recessive
low 1.6%
n = 12,860 dogs · 1 variant tested · OMIA:001572-9615 · omia.org →
Congenital Myasthenic Syndrome (Discovered in the Heideterrier; CHRNE-related; CMS)
Autosomal recessive
low 0.23%
n = 12,880 dogs · 2 variants tested · OMIA:000685-9615 · omia.org →
CHRNEwhat this gene does

CHRNE is a gene involved in the communication between nerves and muscles, helping muscles respond properly to signals.

For your dog: If your dog is from a breed known to carry CHRNE variants, it's worth discussing with your vet, especially if you notice muscle weakness or unusual fatigue.

Chondrodystrophy and Intervertebral Disc Disease Risk (CDDY)
Autosomal dominant
low 0.18%
n = 12,842 dogs · 1 variant tested · OMIA:000157-9615 · omia.org →
FGF4what this gene does

FGF4 influences leg length by affecting bone growth, leading to shorter legs in certain breeds.

For your dog: If your dog is from a breed known to carry this gene, it's worth discussing spinal health with your vet, but being a carrier doesn’t guarantee problems.

Degenerative Myelopathy (DM)
Autosomal recessive (Incomplete penetrance)
low 0.17%
n = 12,881 dogs · 1 variant tested · OMIA:000263-9615 · omia.org →
SOD1what this gene does

SOD1 is a gene that helps protect cells from damage caused by harmful molecules called free radicals.

For your dog: If your dog is a carrier of SOD1 variants, it's worth discussing with your vet, but remember carrier status doesn't mean your dog will get the disease.

Acral Mutilation Syndrome (AMS)
Autosomal recessive
low <0.1%
n = 12,881 dogs · 1 variant tested · OMIA:001514-9615 · omia.org →
GDNFwhat this gene does

GDNF is a gene that helps support nerve cells, especially those involved in sensing pain and movement.

For your dog: If your dog is from a breed that can carry this gene change, it’s worth asking your vet about testing to understand any potential risks.

Congenital Myasthenic Syndrome (Discovered in the Labrador Retriever)
Autosomal recessive
low <0.1%
n = 12,881 dogs · 2 variants tested · OMIA:001928-9615 · omia.org →
Exercise-Induced Collapse (EIC)
Autosomal recessive (Incomplete penetrance)
low <0.1%
n = 12,879 dogs · 1 variant tested · OMIA:001466-9615 · omia.org →
DNM1what this gene does

DNM1 is a gene that helps nerve cells communicate properly by managing how they send signals during muscle activity.

For your dog: If your dog belongs to one of the breeds known to carry this gene variant, it's worth discussing EIC with your vet, especially if your dog is very active or shows signs of weakness during exercise.

Von Willebrand's Disease, Type 1 (vWD 1)
Autosomal recessive
low <0.1%
n = 12,881 dogs · 1 variant tested · OMIA:001057-9615 · omia.org →
Progressive Retinal Atrophy (Discovered in the Swedish Vallhund; MERTK-related)
Autosomal recessive
low <0.1%
n = 12,881 dogs · 1 variant tested · OMIA:001932-9615 · omia.org →
MDR1 (Multidrug Resistance 1) Medication Sensitivity
Autosomal dominant
low <0.1%
n = 12,880 dogs · 1 variant tested · OMIA:001402-9615 · omia.org →
ABCB1what this gene does

ABCB1 is a gene that helps control how certain drugs are processed and cleared from a dog's body.

For your dog: If your dog is from a breed that carries this gene variant, ask your vet about medication sensitivities before giving any new drugs.

Early-Onset Progressive Polyneuropathy (Discovered in the Greyhound)
Autosomal recessive
low <0.1%
n = 12,881 dogs · 2 variants tested · OMIA:002120-9615 · omia.org →
NDRG1what this gene does

NDRG1 is a gene involved in nerve cell function and maintenance, helping keep the nervous system working properly.

For your dog: If your dog is from a breed known to carry NDRG1 variants, it’s worth discussing with your vet, especially if you notice any mobility issues.

Collie Eye Anomaly (CEA)
Autosomal recessive
low <0.1%
n = 12,881 dogs · 1 variant tested · OMIA:000218-9615 · omia.org →
NHEJ1what this gene does

NHEJ1 is a gene involved in repairing breaks in DNA, helping maintain the integrity of genetic information in cells.

For your dog: If your dog belongs to one of the breeds known to carry this gene variant, it's worth discussing testing with your vet to understand any potential eye health risks.

Stargardt Disease (Discovered in the Labrador Retriever)
Autosomal recessive
Pathogenic low <0.1%
n = 12,881 dogs · 1 variant tested · OMIA:002179-9615 · omia.org →
ABCA4what this gene does

ABCA4 is a gene that helps manage the transport of molecules in the retina, the part of the eye responsible for vision.

For your dog: If your dog is from a breed known to carry ABCA4 variants, it's worth discussing eye health with your vet, especially as they age.

Factor VII Deficiency
Autosomal recessive
low <0.1%
n = 12,881 dogs · 1 variant tested · OMIA:000361-9615 · omia.org →
F7what this gene does

The F7 gene helps produce a protein important for blood clotting, which stops bleeding when dogs get injured.

For your dog: If your dog is from a breed known to carry F7 variants, it's worth mentioning to your vet before any surgery or if you notice unusual bleeding.

Cone-Rod Dystrophy (cord1-PRA/crd4)
Autosomal recessive (Incomplete penetrance)
low <0.1%
n = 12,853 dogs · 1 variant tested · OMIA:001432-9615 · omia.org →
RPGRIP1what this gene does

RPGRIP1 is a gene involved in the function of photoreceptor cells in the eye, which help dogs see in different light conditions.

For your dog: If your dog belongs to a breed known to carry RPGRIP1 mutations, it’s worth discussing with your vet to understand the risks and monitor eye health.

Rod-Cone Dysplasia 1a (Discovered in the Sloughi; rcd1a)
Autosomal recessive
low <0.1%
n = 12,875 dogs · 1 variant tested · OMIA:001669-9615 · omia.org →
PDE6Bwhat this gene does

PDE6B is a gene that helps control how the eye processes light signals, crucial for normal vision.

For your dog: If your dog is from a breed known to carry PDE6B mutations, it's worth discussing vision health with your vet, especially if you notice any changes in sight.

Show the other 13, ordered after these by severity, then carrier frequency.
Hyperuricosuria (HUU) <0.1% n = 12,879
Canine Multifocal Retinopathy 1 (Discovered in Mastiff-related breeds; CMR1) <0.1% n = 12,881
Dilated Cardiomyopathy risk factor (Discovered in the Doberman Pinscher; PDK4-related) <0.1% n = 12,881
Neuronal Ceroid Lipofuscinosis 8 (Discovered in the Australian Shepherd; NCL8) <0.1% n = 12,881
Van den Ende-Gupta Syndrome (VDEGS) <0.1% n = 12,875
Musladin-Lueke syndrome (MLS) <0.1% n = 12,876
Dental Hypomineralisation (Discovered in the Border Collie) <0.1% n = 12,877
Dystrophic Epidermolysis Bullosa (Discovered in the Golden Retriever) <0.1% n = 12,881
Muscular Dystrophy (Discovered in the Golden Retriever) <0.1% n = 12,881
Acute Respiratory Distress Syndrome (Discovered in the Dalmatian; ARDS) <0.1% n = 12,879
Episodic Falling (EF) <0.1% n = 12,881
Hereditary Elliptocytosis <0.1% n = 12,881
Macrothrombocytopenia (Discovered in the Norfolk and Cairn Terrier) <0.1% n = 12,881
Source: Donner J et al. 2023. Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651 · Evidence: Limited (DTC ascertainment, tag-SNP proxy) · Confounding MEDIUM · License CC-BY-4.0 · Phene IDs from OMIA (Sydney School of Veterinary Science, The University of Sydney; DOI 10.25910/2AMR-PV70).
Sample size in this breed: 12,881 dogs from the Donner 2023 cohort.
In plain terms

What these results mean for a Golden Retriever

SLC7A9 p.A217T (sold as a cystinuria test)

Marker disputed

23.7% of Golden Retrievers in the Donner 2023 cohort carried it (n=12,881).

  • The curated record finds no support for this variant causing cystinuria, and the researchers who studied it advise against using it as a test.
    OMIA 001880-9615

    “there appears to be no support for the variant to be causal” OMIA 001880-9615

    “strongly recommend not to use "the variant in SLC7A9 as a test to predict the risk of developing cystinuria in male English bulldogs.” OMIA 001880-9615

What to do
A carrier result for this variant does not predict bladder stones. Straining to urinate or blood in the urine is a reason to see a veterinarian whatever a DNA test says.

No test, or a mix
The curated record gives no reason to test for this variant.

Which Mendelian variants matter most for Golden Retrievers?

The Mendelian-disease table above lists 195 variants screened in 12,881 Goldens (Donner 2023). Five matter most by carrier frequency, and the first two matter most by impact.

Ichthyosis (PNPLA1)

Ichthyosis in Goldens is a recessive skin condition caused by a deletion in PNPLA1. Affected dogs have flaky, scaly skin that gets worse with age. It is cosmetic and manageable, not life-threatening. About 27.5% of Goldens in the Donner cohort carry the variant (n=12,881). More than one in four. It is the most common Mendelian variant in the breed and the single most consequential number on this page.

Testing is widely available. The PennGen Laboratory and most commercial DNA labs cover PNPLA1. The Golden Retriever Club of America’s health committee recommends testing breeding stock to avoid carrier-by-carrier pairings. For pet dogs the test is informative but not clinically required.

Retinal atrophy variants (TTC8, PRCD, SLC4A3)

Three progressive retinal atrophy variants run at observable frequency in Goldens. The TTC8-related form is at 2.8% carrier frequency, PRCD (progressive rod-cone degeneration) at 2.7%, and the SLC4A3-related form at 1.6%. All three are recessive: a dog needs two copies to be affected, and affected dogs are well below 1% of the breed.

Affected dogs lose night vision first, then day vision, typically beginning in middle age. The OFA Companion Animal Eye Registry maintains the screening protocol. The GRCA recommends annual eye exams for breeding stock.

What we don’t know

Cancer is the breed’s defining health problem. Roughly 60% of Goldens die of cancer (Morris Animal Foundation GRLS), one of the highest rates of any breed. Hemangiosarcoma and lymphoma together account for more than half of GRLS cancer diagnoses. The Golden Retriever Lifetime Study has spent fourteen years looking for environmental, dietary, and genetic predictors. The honest summary is that the published analyses have come back mostly null. We do not yet have proven dietary prevention strategies for cancer in this breed. The data the GRLS cohort is producing will sharpen that picture in the next few years.

Frequently asked questions about Golden Retrievers

Are Golden Retrievers more likely to get cancer than other breeds? Yes. Roughly 60% of Goldens die of cancer (Morris Animal Foundation), one of the highest rates of any breed. The four dominant cancers are hemangiosarcoma, lymphoma, osteosarcoma, and mast cell tumors. The published environmental and dietary analyses from the GRLS cohort have come back mostly null so far, which means proven prevention strategies are not yet available.

What is the most common genetic disease in Golden Retrievers? Ichthyosis, caused by a variant in PNPLA1. 27.5% of Goldens carry one copy; under Hardy-Weinberg, about 7.6% are expected to be homozygous for the variant (Donner 2023, n=12,881). That genotype class is not the same as a counted clinical “affected” census. It is a cosmetic skin condition, not life-threatening, and is the most common Mendelian variant in the breed.

How long do Golden Retrievers live? The breed-club estimate is 10 to 13.2 years (McMillan 2024 / VetCompass) (Morris Animal Foundation). The atlas-derived figure from the GRLS cohort is 13.15 years, but that median will shift downward as the cohort completes its lifespan. Both numbers belong on this page. The breed-club figure is closer to what an owner should expect today.

Are field-line and show-line Goldens genetically different? The Sniff atlas substrate currently classifies Goldens as a single genetic cluster with an intra-breed RMS distance of 35.8. Show-line and field-line Goldens may differ at finer resolution than the substrate currently captures. Higher-resolution data arriving later this year will resolve this question one way or the other.

What is the GRLS and why does it matter for Golden Retrievers? The Golden Retriever Lifetime Study is a fourteen-year longitudinal study of 3,044 Goldens run by the Morris Animal Foundation. It is the most detailed map of canine health ever assembled in any breed. Sniff is not affiliated with the Morris Animal Foundation. The cohort’s data is what makes the lifespan median, the cancer rate, and the Distinguished Oldies count on this page possible.

Temperament

What Golden Retrievers tend toward

Tendencies from owner surveys of purebred Golden Retrievers — a leaning across the breed, not a prediction for any one dog. A bar’s strength shows how much of that behavior breed actually explains: for most it’s faint, because the rest is your dog, their training, and the life you give them.

Human Sociabilitybreed ~11%
less sociablehighly sociable
Toy-directed Motor Patternsbreed ~18%
toy-directednot toy-directed
Biddabilitybreed ~18%
biddableindependent
Agonistic Thresholdbreed ~9%
assertivediffident
Arousal Levelbreed ~8%
arousedcomposed
Proximity Seekingbreed ~13%
affectionatealoof
Environmental Engagementbreed ~9%
high engagementlow engagement
Dog Sociabilitybreed ~8%
less sociablehighly sociable
n = 158 dogs · Morrill et al. 2022, Science, Darwin's Ark (CC0)
Owner-reported purebreds; each factor n ≥ 25. "Breed ~%" is the share of this behavior explained by breed.
Names & origins

Identified as Golden Retriever (VBO:0200610) in the Vertebrate Breed Ontology (Mullen et al. 2025, CC-BY 4.0) · registry IDs FCI 111 · iDog 116 · VeNom 14609.

For researchers Population genetics, disease models and every recorded condition Open the research detail for the Golden Retriever
What the atlas says about Golden Retriever

In the atlas, the Golden Retriever clusters consistently as Golden Retriever (100% of the 3523 dogs here).

High breed predictability score (0.93), individual dogs of this breed reliably cluster together genetically. Well-sampled in CanVAS: 3,523 dogs.

Median lifespan is 13.15 years, about 1.5 years longer than a typical dog of 29.5 kg, an unusually positive longevity for this size.

Genetic dimensions · CanVAS atlas

What the atlas genotypes say about Golden Retriever

Computed from the 14,478 CanVAS dogs in the Atlas, on an imputed genotype backbone: 77,215 directly typed sites per dog, imputed to 9.67 million variants.

The confidence below counts dogs, not reads: it is the size of the sample, and it is separate from how the genotypes were measured.

Dogs in the Atlas
3,523Founders
3,197 from GRLS, 247 from Hayward2016, 57 from Shannon
Genetic diversity
0.28Moderate
Mean heterozygosity across the breed. 80th most diverse of 107 ranked populations.
What does genetic diversity mean?

How varied a breed's gene pool is — the share of gene spots where a typical dog of the breed carries two different versions rather than two identical ones.

How to read it: Higher = more diverse. Among well-sampled breeds it ranges roughly 0.22 (least diverse) to 0.33 (most diverse).

Diversity is a strength, not a verdict on any individual dog. Lower diversity means it's worth paying attention to recessive-risk testing — not that a dog is doomed.

Cluster structure
Single tight cluster
Intra-breed RMS distance: 35.80
What does within-breed variation mean?

How much individual dogs within the breed differ from each other genetically.

How to read it: Higher = more internal variety among individuals of the breed.

Sensitive to how many dogs of the breed we've sampled.

Related breeds
Built from
Close cousins
Distant kin · one shared founding ancestor
In the Sporting group
Explore the full lineage map →
VBO foundation stock (breeding records) · AKC breed group
Relatedness is documented lineage + kennel family. Genetic-ancestry distance measures diversity, not kinship, so it isn't used here.
How long they live
13.2years (life expectancy)
95% CI 13.1–13.2 · VetCompass, McMillan 2024, n=11,506. source
Published estimate: 10 to 12 years (Morris Animal Foundation).
What does typical lifespan mean?

The median age dogs of the breed tend to reach.

How to read it: Higher = longer-lived. Compare to longevity-for-size to see whether it's just a size effect.

Drawn from population lifespan records; individual dogs vary widely with care, genetics, and luck.

n = 3,523 dogs · high sample · CanVAS (Brundage 2026) · Sniff Atlas
Comparative oncology

Golden Retrievers are a natural model for human cancer.

Some cancers appear in Golden Retrievers and in people driven by the same somatically-altered genes, cohort by cohort and cited on both sides. That makes this breed part of how we understand, and one day treat, the human disease. This is not a prediction about your dog, it is a window into the biology we share.

The dog and human hemangiosarcoma model →
A gift to human medicine

Golden Retrievers are a natural model for human disease

Because the same genes cause the same conditions across species, the inherited conditions documented in Golden Retrievers help researchers understand, and work toward treating, the human diseases they model. This is the dog advancing human medicine. The breed models the human disease; it does not have it, and this is not a prediction for your dog.

Human equivalents via OMIA → Mondo / OMIM. Model-of, not identity. The named gene is the canine locus, not a claim that a pet has the human disease.
Documented in OMIA

Every condition recorded in the Golden Retriever

Beyond the testable carriers above, OMIA's literature catalogue records 43 genetic conditions in the Golden Retriever, 37 of which have a known human equivalent. This is the documented landscape across all Golden Retrievers ever studied, not a prediction for any one dog.

Plus 25 more conditions recorded in the Golden Retriever in OMIA.

Online Mendelian Inheritance in Animals (OMIA); Nicholas, Tammen & Sydney Informatics Hub, DOI 10.25910/2AMR-PV70
Documented in the breed's literature is not carrier status and not a forecast for an individual dog. Human equivalents are mapped via Mondo/OMIM. Carrier frequencies (above) are the separately-measured testable subset (Donner 2023).
The oldest of them

What protected the golden retrievers who outran the odds.

Goldens in the GRLS cohort who reached age 12 or older without a malignant cancer diagnosis. In a breed where roughly 60% die of cancer and the Morris Animal Foundation's lifespan estimate is 10 to 12 years, reaching 12 without cancer is extraordinary. They carry the Distinguished Oldies badge in the atlas. Understanding what protected them is the most valuable single question the Golden Retriever literature can answer.

196 Distinguished Oldies in the atlas Browse the Heroes →
The data behind this page

Where every number on this page came from.

This page draws on three primary data sources. Carrier frequencies for the Mendelian section come from Donner et al. 2023 (CC-BY-4.0). We grade these data at evidence Limited because the cohort is a direct-to-consumer ascertainment, which biases toward owners who chose to test their dogs. The panel also uses tag-SNP proxies for some variants rather than direct causal-variant assays. Limited is a study-design grade, not a quality grade: the Donner cohort is the largest open canine-genotype dataset in existence and we are grateful for it. We rate the confounding MEDIUM.

Population-genetic dimensions (heterozygosity, intra-breed PCA distance, nearest neighbors, trait-locus frequencies) come from CanVAS (Brundage 2026), harmonized through the Sniff Atlas. The exact release date and verification commit are pinned at the bottom of the page so a researcher can trace a number back to a specific snapshot. The disease-gene-variant graph comes from OMIA (Online Mendelian Inheritance in Animals; Nicholas, Tammen, and the Sydney Informatics Hub at the Sydney School of Veterinary Science, The University of Sydney; retrieved April 2026, DOI 10.25910/2AMR-PV70).

Longitudinal data on the 196 Distinguished Oldies above comes from the Golden Retriever Lifetime Study (Labadie et al. 2022, doi:10.1371/journal.pone.0269425). Sniff is not affiliated with the Morris Animal Foundation. We are grateful for their work and for every family and every dog that made this study real.

What this page does not yet have. Inheritance modes and per-disease penetrance evidence from Donner 2023 are in the structured data for every variant the panel covers. Mondo, OMIM, Ensembl, and HGNC cross-references live on the gene and disease pages this page links to, rather than being repeated here. What is still absent from this breed page is anything not in the cited panel, and each such gap carries its cause where it appears.

How to cite this page. The computed dimensions on this page are derived from the open Sniff Atlas v1.0.1 (Gehring 2026, doi:10.5281/zenodo.20566358, CC-BY 4.0). Full citation formats including BibTeX, RIS, and CITATION.cff at sniff.world/cite.

Some things about living with a golden retriever never make it into a database. Add what you know as a Keeper, in your words →

Lived experience, kept beside the science.
Add your golden retriever to the atlas

We have 3,523 golden retrievers. We do not have yours.

Field-line Goldens are underrepresented relative to show lines. Goldens older than 12 without a cancer diagnosis are scientifically among the most valuable dogs in the breed and we always need more of them. European imports are underrepresented relative to North American lines. If your golden retriever fits any of these gaps, adding them does measurable scientific work.

Add your golden retriever now as a Charted star
Want to wait for DNA uploads?

Leave your email and we'll let you know the moment DNA uploads open for Golden Retrievers.

References
  1. Donner J, Freyer J, Davison S, Anderson H, Blades M, Honkanen L, et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651. doi:10.1371/journal.pgen.1010651
  2. Brundage DM (2026). CanVAS: A Harmonized and Imputed Canine Variant Atlas. bioRxiv. doi:10.64898/2026.04.13.718238
  3. Nicholas, F.W., Tammen, I., & Sydney Informatics Hub. (2026). Online Mendelian Inheritance in Animals (OMIA) [dataset]. The University of Sydney. https://omia.org. doi:10.25910/2AMR-PV70 (retrieved April 2026).
  4. Labadie J, et al. (2022). Cohort profile: The Golden Retriever Lifetime Study (GRLS). PLOS ONE 17(6):e0269425. doi:10.1371/journal.pone.0269425
  5. Adin D, DeFrancesco TC, Keene B, et al. (2019). Echocardiographic phenotype of canine dilated cardiomyopathy differs based on diet type. J Vet Cardiol. doi:10.1016/j.jvc.2018.11.002
  6. US Food and Drug Administration (2022). Questions & Answers: FDA's work on potential causes of non-hereditary DCM in dogs. https://www.fda.gov/animal-veterinary/animal-health-literacy/questions-answers-fdas-work-potential-causes-non-hereditary-dcm-dogs
  7. Orthopedic Foundation for Animals (OFA). Golden Retriever hip dysplasia statistics. https://www.ofa.org/diseases/hip-dysplasia/
  8. Tindle AN, et al. (2024). Environmental exposures and cancer risk in the Golden Retriever Lifetime Study cohort. https://www.morrisanimalfoundation.org/golden-retriever-lifetime-study
Last updated
Sources: CanVAS (Brundage 2026) · Donner 2023 · OMIA · GRLS (Labadie et al. 2022)